Gary D. Glick,Alexander R. Hurd,Clarke B. Taylor,Chad A. VanHuis
申请号：
US15421729
公开号：
US20170267643A1
申请日:
2017.02.01
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The invention provides pyrazolyl guanidine compounds that inhibit F1Fo-ATPase, and methods of using pyrazolyl guanidine compounds as therapeutic agents to treat medical disorders, such as an immune disorder, inflammatory condition, or cancer.
